 Carcinoma, Squamous Cell
"Carcinoma, Squamous Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Descriptor ID |
D002294
|
| MeSH Number(s) |
C04.557.470.200.400 C04.557.470.700.400
|
| Concept/Terms |
Carcinoma, Squamous Cell- Carcinoma, Squamous Cell
- Carcinomas, Squamous Cell
- Squamous Cell Carcinomas
- Squamous Cell Carcinoma
- Carcinoma, Squamous
- Carcinomas, Squamous
- Squamous Carcinoma
- Squamous Carcinomas
- Carcinoma, Epidermoid
- Carcinomas, Epidermoid
- Epidermoid Carcinoma
- Epidermoid Carcinomas
- Carcinoma, Planocellular
- Carcinomas, Planocellular
- Planocellular Carcinoma
- Planocellular Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Squamous Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Squamous Cell".
This graph shows the total number of publications written about "Carcinoma, Squamous Cell" by people in this website by year, and whether "Carcinoma, Squamous Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 2 | 2 | 4 | | 1993 | 1 | 0 | 1 | | 1994 | 3 | 0 | 3 | | 1995 | 5 | 0 | 5 | | 1996 | 2 | 1 | 3 | | 1997 | 7 | 1 | 8 | | 1998 | 2 | 1 | 3 | | 1999 | 3 | 4 | 7 | | 2000 | 3 | 0 | 3 | | 2001 | 3 | 5 | 8 | | 2002 | 2 | 2 | 4 | | 2003 | 2 | 2 | 4 | | 2004 | 3 | 5 | 8 | | 2005 | 6 | 3 | 9 | | 2006 | 14 | 2 | 16 | | 2007 | 9 | 2 | 11 | | 2008 | 14 | 1 | 15 | | 2009 | 7 | 4 | 11 | | 2010 | 9 | 6 | 15 | | 2011 | 23 | 2 | 25 | | 2012 | 18 | 1 | 19 | | 2013 | 25 | 0 | 25 | | 2014 | 16 | 6 | 22 | | 2015 | 18 | 2 | 20 | | 2016 | 23 | 2 | 25 | | 2017 | 16 | 2 | 18 | | 2018 | 15 | 1 | 16 | | 2019 | 11 | 2 | 13 | | 2020 | 8 | 2 | 10 | | 2021 | 7 | 1 | 8 | | 2022 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Squamous Cell" by people in Profiles.
-
Castellano GM, Zeeshan S, Garbuzenko OB, Sabaawy HE, Malhotra J, Minko T, Pine SR. Inhibition of Mtorc1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma. Mol Cancer Ther. 2022 Sep 06; 21(9):1381-1392.
-
Shiao JC, Holt D, Ladbury C, Gao D, Jones B, Karam SD, Amini A. The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. Oral Oncol. 2022 07; 130:105907.
-
Nguyen KA, Keith MJ, Keysar SB, Hall SC, Bimali A, Jimeno A, Wang XJ, Young CD. Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell-like properties and phosphoinositide 3-kinase inhibitor insensitivity. Mol Carcinog. 2022 07; 61(7):664-676.
-
Chen SMY, Popolizio V, Woolaver RA, Ge H, Krinsky AL, John J, Danis E, Ke Y, Kramer Y, Bian L, Nicklawsky AG, Gao D, Liu S, Chen Z, Wang XJ, Wang JH. Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers. J Exp Clin Cancer Res. 2022 Apr 02; 41(1):123.
-
Krop IE, Jegede OA, Grilley-Olson JE, Lauring JD, Mitchell EP, Zwiebel JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Kono SA, Ford JM, Garcia AA, Sui XD, Siegel RD, Slomovitz BM, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT. Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I. JCO Precis Oncol. 2022 02; 6:e2100424.
-
Lightner AL, Vaidya P, McMichael J, Click B, Regueiro M, Steele SR, Hull TL. Anal Squamous Cell Carcinoma in Ulcerative Colitis: Can Pouches Withstand Traditional Treatment Protocols? Dis Colon Rectum. 2021 09 01; 64(9):1106-1111.
-
Strait AA, Woolaver RA, Hall SC, Young CD, Karam SD, Jimeno A, Lan Y, Raben D, Wang JH, Wang XJ. Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFß/PD-L1 blockade-treated squamous cell carcinoma. Commun Biol. 2021 08 25; 4(1):1005.
-
Blake EA, Ross MS, Ross ME, Matsuo K, Silverstein ET, Torno LR, Bhargava R, Post MD, Da Silva DM, Taylor S, Walia S, Roman L, McEachron TA. Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpoints. Arch Gynecol Obstet. 2022 02; 305(2):439-447.
-
Kachnic LA, Winter KA, Myerson RJ, Goodyear MD, Abitbol AA, Streeter OE, Augspurger ME, Schefter TE, Katz AW, Fisher BJ, Henke LE, Narayan S, Crane CH. Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer. Int J Radiat Oncol Biol Phys. 2022 01 01; 112(1):146-157.
-
Rischin D, Khushalani NI, Schmults CD, Guminski A, Chang ALS, Lewis KD, Lim AM, Hernandez-Aya L, Hughes BGM, Schadendorf D, Hauschild A, Thai AA, Stankevich E, Booth J, Yoo SY, Li S, Chen Z, Okoye E, Chen CI, Mastey V, Sasane M, Lowy I, Fury MG, Migden MR. Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis. J Immunother Cancer. 2021 08; 9(8).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|